Skip to main content
SpringerLink
Log in

Il trattamento delle patologie acido-correlate ai tempi delle delibere regionali: altre ottiche

  • Lettere al Direttore
  • Published:
PharmacoEconomics Italian Research Articles

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Bibliografia

  1. Tonini M. Il trattamento delle patologie acido-correlate ai tempi delle delibere regionali sull’equivalenza terapeutica dei PPI. (Lettera). PharmacoEconomics-Italian Research Articles 2007; 9: 127–31

    Google Scholar 

  2. Meredith P. Bioequivalence and other unresolved issues in generic drug substitution. Clin Ther 2003; 11: 2875–89

    Article  Google Scholar 

  3. Pearce GA, McLachlan AJ, Ramzan I. Bioequivalence: how, why, and what does it really mean? J Pharm Pract Res 2004; 34: 195–200

    Google Scholar 

  4. Motola D, De Ponti F. Generic versus brand-name medicinal products: are they really interchangeable? Dig Liv Dis 2006; 38: 560–2

    Article  CAS  Google Scholar 

  5. www.sign.ac.uk/guidelines/fulltext/70/section3.html

  6. Fonti: OsMed e IMS Health, 2007

  7. Frank RG. The ongoing regulation of generic drugs. N Engl J Med 2007; 357: 1993–6

    Article  PubMed  CAS  Google Scholar 

  8. Bowe C. FDA “troppo intima” con le compagnie farmaceutiche. Articolo sul Financial Times del 20/21 novembre 2004

  9. Steinbrook R. Registration of clinical trials. N Engl J Med 2004; 351: 1820–2

    Article  PubMed  CAS  Google Scholar 

  10. Steinbrook R. Public access to NIH-funded research. N Engl J Med 2005; 352: 1739–41

    Article  PubMed  CAS  Google Scholar 

  11. Smith SW. Sidelining safety — The FDA’s inadequate response to the IOM. N Engl J Med 2007; 357: 960–3

    Article  PubMed  CAS  Google Scholar 

  12. De Angelis C, Drazen JM, Frizelle FA, et al.; International Committee of Medical Journal Editors. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Engl J Med 2004; 351: 1250–1

    Article  PubMed  Google Scholar 

  13. www.fda.gov/cder/ob/docs/preface/eclink.html

Download references

Author information

Authors and Affiliations

  1. Dipartimento Programmazione Acquisto e Controllo (DiPAC), ASL Provincia di Pavia, Italia

    Mirosa Dellagiovanna, Carlo Cerra & Pietro Fratino

Authors
  1. Mirosa Dellagiovanna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carlo Cerra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pietro Fratino
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dellagiovanna, M., Cerra, C. & Fratino, P. Il trattamento delle patologie acido-correlate ai tempi delle delibere regionali: altre ottiche. Pharmacoeconomics-Ital-Res-Articles 10, 49–52 (2008). https://doi.org/10.1007/BF03320640

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03320640

Search

Navigation